Our Mission
Improve access to healthcare through innovative home testing options. Lead a unified “one health” defense against vector-borne pathogens for every member of the family—two-legged or four.
Changing how Lyme disease is detected.
LymeAlert was created to make early detection easier and to answer the question of what to do after a tick bite. Our solution is to test the tick for important data and informed decision-making.
Our mission, vision and approach
Our vision
Building beyond a single test. To become the world’s leading platform for early detection, intelligence, and response to vector-borne disease—starting with Lyme and expanding wherever risk emerges.
Our approach
Built on science, designed for early detection. LymeAlert is built using lab-based detection principles to detect the pathogen that can cause Lyme disease in ticks. By focusing on early-stage exposure and testing the tick, it provides answers in minutes instead of days, helping people make faster, more informed decisions.
Dr. Michelle Ewy, CSO & Co-founder
“Early detection only works if it’s accurate, accessible, and easy to use.”
— Dr. Michelle Ewy, CSO & Co-founder
Our Team
A team across medical, science, data, and operations, focused on making healthcare accessible and building a platform for early detection.
CEO and Co-founder
Erin Dawicki
Physician Associate with nearly two decades of clinical experience. She has held teaching and clinical roles at Boston Children’s Hospital, Tufts University School of Medicine, and in private practice.
CSO and Co-founder
Dr. Michelle Ewy
Scientist and Air Force veteran with 20+ years in chemistry, biotechnology, and diagnostic development.
COO and Co-founder
Brenda Ong
Operations and strategy leader with experience in public safety, government systems, and large-scale coordination.
CFO
Craig McLaughlin
CPA with more than a decade of experience in accounting, tax, financial planning, and the public sector finance leadership.
CMO
Casey Tilli
Marketing executive with 20+ years of experience leading campaigns, partnerships, growth, and brand launches.
VP of Product
Susanna Keeton
Product leader focused on turning early innovation into market-ready solutions and successful launches.
Founding Researcher
Lewis Shotton
Bioengineer and researcher with experience in material synthesis and lateral flow assay development for disease detection.
Director, Research Strategy and Execution
Julio Lorenzo
Immunologist with deep expertise in vaccine development, biomarker discovery, and antibody characterization.
MIT Pozen Fellow (Summer 2026) & Research Intern
Lia Gonzales
Don’t wait for symptoms. Take action early.
Preorder a test kitAdvisory Board
Our advisory board includes leaders across biotechnology, veterinary medicine, public health, research, and marketing.
Mark Reilly, DVM
Owner of South Shore Equine Hospital and Author of “Lyme disease in Horses.”
Marjorie Radlo-Zandi, MBA
Entrepreneur and Investor Board Member of QSM Diagnostics.
Charlie Cooney, PhD
MIT Prof Emeritus, Chemical Engineering Founder, Consultant & Board Member of multiple Biotech companies.
John van Amsterdam, PhD
Biotech Lawyer Shareholder at Wolf Greenfield, Biotech Practice Expertise.
Michelle Chao, BEng
Co-founder, Phoenix Tailings, Forbes 30 under 30.
Jane Karol, PsyD
Equine industry leader and owner of Bear Spot Farm.
Rohini Kumar
Marketing expert with success driving retail, brand, and product marketing for Target, Disney, and Atlassian.
Supported By
- The Huang-Hobbs BioMaker Space
- Bay Area Lyme Ventures
- MIT Sandbox Innovation Fund Program
- MIT PKG IDEAS
- MIT delta v
- CIC
- MIT Venture Mentoring Service
- AE
In the News
Crushing Lyme disease one tick at a time.